Micro-Scale Engineering –IIILab-on-a-Chip and Cancer Detection
Y. C. LeeDepartment of Mechanical Engineering
University of ColoradoBoulder, CO 80309-0427
September 16, 20081
2
Three Lectures
• Tuesday, September 2- MEMS Introduction
• Tuesday, September 9- BioMEMS, Lab-on-a-Chip
• Tuesday, September 16 - BioMEMS, Cancer cell analysis, implantable MEMS
Contents• Biochip and bioMEMS• Cancer cell detection
- molecular markers- electrophoresis, electro-osmosis and dielectrophoresis- fluid flow fractionation- cancer detection
• Injectable MEMS- microneedles
• Implantable MEMS- drug delivery devices
3
Microprocessor in 2007
An Intel microprocessor announced in November 2007: 214mm2 (~12mmX18mm) and 820 million transistors 5
Contents• Biochip and bioMEMS• Cancer cell detection
- molecular markers- electrophoresis, electro-osmosis and dielectrophoresis- fluid flow fractionation- cancer detection
• Injectable MEMS- microneedles
• Implantable MEMS- drug delivery devices
9
Molecular Fingerprints of Cancer Cells
10
Localization of p16INK4a in squamous mucosa. Panel A, benign squamous mucosa; Panel B, CIN 1; Panel C, CIN 3; Panel D, SCC.
14
Biopsy and Cancer Detection
• Precancerous molecular or chromosomal abnormalities are undetectable.• Geographic misses frequently occur leading to false negative biopsies.• Cancers are often multifocal. A positive biopsy at one site may not give a full picture of the
extent of disease if the cancer is multifocal or has extended to “skip areas”.• There is no standard technique for determining genetically abnormal tissue at resection
margins in the operating room. Such abnormalities are clinically undetectable and may lead to recurrence despite “complete resection” as determined by frozen section technique.
Punch Microtome Detection system
15
A micro-thin tissuetaken from the abnormalarea using micropunchwithout anesthetic
Lab-on-a-ChipCarcinoma detection by measuring light absorption and fluorescence of tissue
InstantBiopsy
Light-Guided Micropunch-Based Instant Biopsy
16
Epoxy with glass beads as spacers
Micro-thin Tissue
Silicon
Window etched
Sharp blades made bydouble-side polishing
Micropunch
17
Contents• Biochip and bioMEMS• Cancer cell detection
- molecular markers- electrophoresis, electro-osmosis and dielectrophoresis- fluid flow fractionation- cancer detection
• Injectable MEMS- microneedles
• Implantable MEMS- drug delivery devices
19
Electrophoresis (CoventorWare)
Vep= μep E
Velocity of Charged Species = Eletrophoretic mobility of the ion in the carrier species X Electrical Field
Strength
Note: in most cases, the carrier does not move under electrophoresis.20
Electrophoresis and Electroosmosis• Electrophoresis :
The movement of a charged surface plus attached material relative to stationary liquid by an applied electric field. Mobile particles, Stationary liquid.
• Electroosmosis :The movement of liquid relative to a stationary charged surface by an applied electric field.Mobile liquid, Stationary cell wall.
22
Electrochemical double layer and Electroosmosis
-------
-------
+ -- ++ -- ++ -- +
++++++
++++++
1
2
1
Electrolytepulled byelectricalfield23
Dielectrophoresis
1)
2)
3) reverse the field?- time to build up charges- AC frequency effect
26
1)
2)
-
What if the particle itself were non-polarizable and it were suspended in a polarizable medium (e.g. a gas bubble suspended in water)?
Negative Dielectrophoresis
27
Dielectrophoresis
Two different particles in a non-uniform electric field. The particle on the left is more polarisable than the surrounding medium and is attracted towards the strong field at the pin electrode, whilst the particle of low polarisability on the right is directed away from the strong field region.
28
Molecules
Inert particles
Entities with a singlemembrane (virus, prokaryotesand eukaryotes with small nucleii)
Complex cells (plant cellsor mammalia cells with large nucleii)
Simulation
Interface between particle and medium
fCM is the Clausium-Mossotti factor which describes the frequency-dependent dielectri characteristics of the particle and its surroundings.
Applied AC frequency31
Electrochemical double layer and Electroosmosis
-------
-------
+ -- ++ -- ++ -- +
++++++
++++++
1
2
1
Electrolytepulled byelectricalfield33
Dielectric constant
Electrical conductivity
Dielectrophoretic properties
point
Solid particle
A compartmentwith an envelop
Two compartmentswith an envelop
Applied AC frequency
Clausius-Mossotti factor
34
DEP Trapping to Collect Tumor Cells (repelling by negative DEP)
Electrode
Slow fluid flow
Breast tumor cells
Peripheral blood mononuclear cells (PBMNC)
One tumor cell out of 2 x 106 PBMNCs. 35
DEP Trapping (positive DEP)
Electrode
Slow fluid flow
To collect all viable cells but reagents, dead cells or debris.
AC frequencies > 200 KHz 36
Field Flow Fractionation (FFF)
• Narrow channel with the maximum velocity along the centerline.
• Large particles Small diffusion coefficients Closer to the wall Leave the column late.
• Particles susceptible to the field applied Closer to the wall Leave the column late.
38
DEP Collection Spectra
Breast Cancel Cell MDA231
T-lymphocytes
Erythrocytes
Crossoverfrequencies
Repulsion
Trapping
41
Parameters Affecting Cell Properties
• Membrane thickness• Effective area• Dielectric constant• Electrical conductivity
0.8 μF/cm2 for smooth biological membrane15 μF/cm2 for highly convoluted hepatocyte membrane1.2 to 4 μF/cm2 are typical for mammalian cells
42
Eletrosmear for normal
and cultured tumor cells
At their crossover frequencies, cells touch down on the slide surface and are captured by the binding agent. 45
Spiral Electrodes to Concentrate
Cells
Human erythrocytes infectedby the malarial agent Plasmodium falciparumwere discriminated fromuninfected cells and focusedto the center.
49
Molecular Recognition and Sensing
• 5-um beads• 100 tumor cells+250 beads (10 types)
focused on an area with 50-um in diameter
109 cells/ml held in contact with 2x 109 beads/ml carrying molecular probes.
53
Contents• Biochip and bioMEMS• Cancer cell detection
- molecular markers- electrophoresis, electro-osmosis and dielectrophoresis- fluid flow fractionation- cancer detection
• Injectable MEMS- microneedles
• Implantable MEMS- drug delivery devices
54
Out-of-Plane Microneedles
200 um tall, 425 um base diameter tapering to 40 um lumen and 750 um pitch 55
Injectable MEMS
• Microneedles• Injectable Micromodules
- deliver electronic devices such as neuromuscular stimulators to the human body through large-gauge hypodermic needles.
59
Contents• Biochip and bioMEMS• Cancer cell detection
- molecular markers- electrophoresis, electro-osmosis and dielectrophoresis- fluid flow fractionation- cancer detection
• Injectable MEMS- microneedles
• Implantable MEMS ( in vivo devices)- drug delivery devices
60
Biocompatibility• Cytotoxic?Irritants?
- single crystal silicon, polycrystalline silicon, silicon dioxide, single-crystal silicon carbide and titanium are O.K.
• Biofouling?- adsorption of biomolecules (peptides and proteins) followed by cells frequently leads to device fouling and failure.
61
Surface Modification
• Surface Immobilized Polymers- poly (ethylene glycol) (PEG) to inhibit protein adsorption.
• Self-assembled monolayer (SAM)- Oligo(ethylene glycol) terminated alkanethiol moiety to passivate surfaces against protein and cellular adsorption.
62
Removal of an anode membrane to initiate release from a reservoir
Gold was chosen as a model membrane material because it is easily deposited and patterned, has a low reactivity with other substances and resists spontaneous corrosion in many solutions over the entire pH range. However, the presence of a small amount of chloride ion creates an electric potential region which favours the formation ofsoluble gold chloride complexes.
65
Sodium Fluorescein released into phosphate-buffered saline
1.04 Volt w.r.t. saturated calomel reference electrodefor 30 seconds
66
Pulsatile release of multiple substances from a single microchip device
Release rate of 45Ca2+ ions (open triangles; vertical scale in units of 53 nCi min-1) and sodium Fluorescein (filled circles; in units of ng min-1) into 0.145M NaCl solution over several hours
68
Implantable MEMS
• Biosensors- for in vivo diagnostics- pH, analytes, blood pressure, tissue and body fluids.
• Stents• Immunoisolation Devices
- cell containing microcapsule to prevent immunorejection.
• Drug Delivery Systems
69